サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566792

皮膚充填剤市場：タイプ別、性別、サービスプロバイダー別：世界機会分析と産業予測、2024～2033年

Dermal Filler Market By Type (Hyaluronic acid , Calcium Hydroxylapatite , Poly L lactic Acid, Others), By Gender By Service Provider : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日: | 発行: Allied Market Research | ページ情報: 英文 280 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.74円
皮膚充填剤市場：タイプ別、性別、サービスプロバイダー別：世界機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

皮膚充填剤市場

皮膚充填剤市場は、2023年に63億米ドルと評価され、2024～2033年までCAGR 10.3%で成長し、2033年には168億米ドルに達すると予測されています。

皮膚充填剤は、皮膚に注入するジェル状の物質で、皮膚のボリュームを回復させ、ほうれい線やしわを滑らかにし、顔の輪郭を強調します。皮膚充填剤の注入は非外科的なプロセスであり、注入された充填剤タイプにもよるが、即座に結果が現れ、数ヶ月から数年間持続します。ヒアルロン酸は、皮膚に潤いを与え、ボリュームを出すために使用される皮膚充填剤の最も一般的な成分です。合成充填剤とは別に、自然な形の皮膚充填剤もあり、これは人の他の身体部分から採取した脂肪を目的の身体部分に注入するものです。このプロセスは、自家脂肪移植という用語で知られています。

早い段階での老化症状の発生が皮膚充填剤市場の主要促進要因の一つです。さらに、ソーシャルメディアの影響による個人、特に女性の美意識の高まりが、皮膚充填剤の需要を押し上げています。最近では、生体刺激充填剤が体内の天然コラーゲンの産生を促進するため、個人の間で人気を集めています。これらの充填剤は、体内の自然な再生プロセスを促進するため、化学充填剤とは比較になりません。

しかし、皮膚充填剤注射を投与する費用はかなり高く、多くの人々がその利点を利用するのを妨げています。さらに、処置後の合併症や副作用は、いくつかの個人で非常に有害であり、それゆえ、いくつかの個人がそのような注射を投与することについて消極的になります。副作用の可能性にもかかわらず、皮膚充填剤の症例は年々増加しています。国際美容整形外科学会は、2023年に世界中の外科的と非外科的美容整形手術の統計を決定するための調査を実施しました。この調査によると、ヒアルロン酸充填剤の症例は2023年に29％増加し、皮膚充填剤の症例は米国で最大となりました。

セグメントレビュー

皮膚充填剤の世界市場は、タイプ、性別、サービスプロバイダー、地域に区分されます。タイプ別では、市場はヒアルロン酸（HA）、カルシウムヒドロキシルアパタイト（CaHA）、ポリL乳酸、その他に分けられます。性別では、男性と女性に二分されます。サービスプロバイダー別では、専門・皮膚科クリニック、病院、その他に分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

主要調査結果

タイプ別では、ヒアルロン酸（HA）セグメントが2023年の市場で最大の収益を上げました。

性別では、女性セグメントが2023年の皮膚充填剤市場を独占しました。

サービスプロバイダー別では、病院セグメントが2023年に最大の利害関係者でした。

地域別では、北米が2023年に最も高い収益を上げました。

本レポートのカスタマイズの可能性（追加費用とスケジュールが必要です。）

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • 主要参入企業の詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 皮膚充填剤市場：タイプ別

  • 市場概要
  • ヒアルロン酸（HA）
    • 年齢層
      • 13～39歳
      • 40～54歳
      • 55～69歳
  • カルシウムハイドロキシアパタイト（CaHA）
  • ポリL乳酸
  • その他

第5章 皮膚充填材市場：性別

  • 市場概要
  • 男性
  • 女性

第6章 皮膚充填剤市場：サービスプロバイダー別

  • 市場概要
  • 専門クリニックと皮膚科クリニック
  • 病院
  • その他

第7章 皮膚充填剤市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の皮膚充填剤市場
    • カナダの皮膚充填剤市場
    • メキシコの皮膚充填剤市場
  • 欧州
    • 主要市場動向と機会
    • ドイツの皮膚充填剤市場
    • フランスの皮膚充填剤市場
    • 英国の皮膚充填剤市場
    • イタリアの皮膚充填剤市場
    • スペインの皮膚充填剤市場
    • その他の欧州の皮膚充填剤市場
  • アジア太平洋
    • 主要市場動向と機会
    • 日本の皮膚充填剤市場
    • 中国の皮膚充填剤市場
    • インドの皮膚充填剤市場
    • オーストラリアの皮膚充填剤市場
    • 韓国の皮膚充填剤市場
    • その他のアジア太平洋の皮膚充填剤市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの皮膚充填剤市場
    • サウジアラビアの皮膚充填剤市場
    • 南アフリカの皮膚充填剤市場
    • その他のラテンアメリカ・中東・アフリカの皮膚充填剤市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Teoxane Laboratories
  • Cutera Inc
  • Elan Aesthetics Inc
  • Bioxis Pharmaceutical
  • AbbVie Laboratories
  • Sinclair Pharma
  • Sosum Global
  • Revance Therapeutics
  • Galderma SA
  • Merz Pharma
目次
Product Code: A07289

Dermal Filler Market

The dermal filler market was valued at $6.3 billion in 2023, and is projected to reach $16.8 billion by 2033, growing at a CAGR of 10.3% from 2024 to 2033.

Dermal filler is a gel-like substance injected into the skin to restore its volume, smooth out its lines & wrinkles, and enhance the contours of the face. The injection of derma fillers is a non-surgical process which shows instant results and lasts for a few months to years, depending on the type of filler injected. Hyaluronic acid is the most common component of derma fillers used to hydrate and volumize the skin. Apart from synthetic fillers, there is a natural form of derma filler where fat from some other body part of a person is injected into the target body part. This process is known by the term - autologous fat grafting.

Rise in occurrence of ageing symptoms at an early stage is one of the major drivers of the dermal filler market. Moreover, increase in aesthetic awareness among individuals, particular females, due the influence of social media is boosting the demand for dermal fillers. In recent times, biostimulatory fillers are acquiring traction among individuals as they promote the production of natural collagen in the body. These fillers promote the natural regenerative process inside the body, hence are not comparable to chemical fillers.

However, the expenses of administering dermal filler injections are significantly high, which prevent a large population from availing the benefits. In addition, the post-procedure complications and side-effects are highly adverse in some individuals, hence making several individuals reluctant about administering such injections. Despite the chances of side effects, the cases of dermal fillers are increasing every year. The International Society of Aesthetic Plastic Surgery conducted a survey in 2023 to determine the statistics of surgical and non-surgical cosmetic procedures around the globe. According to this survey, named, International Survey on Aesthetic/Cosmetic Procedures, the cases of hyaluronic acid fillers upsurged by 29% in 2023, with maximum derma filler cases occurring in the U.S.

Segment Review

The global dermal filler market is segmented into type, gender, service provider, and region. On the basis of type, the market is divided into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly L lactic acid, and others. By gender, it is bifurcated into male and female. Depending on service provider, it is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the hyaluronic acid (HA) segment generated the largest revenue in the market in 2023.

By gender, the female segment dominated the dermal fillers market in 2023.

Depending on service provider, the hospitals segment was the largest stakeholder in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global dermal filler market are Teoxane Laboratories, Cutera Inc, Elan aesthetics Inc, Bioxis pharmaceutical, AbbVie Laboratories, Sinclair Pharma, Sosum Global, Revance Therapeutics, Galderma SA, and Merz Pharma. These players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Hyaluronic acid (HA)
    • Age group

◦ 13 to 39

◦ 40 to 54

◦ 55 to 69

  • Calcium Hydroxylapatite (CaHA)
  • Poly L lactic Acid
  • Others

By Gender

  • Male
  • Female

By Service Provider

  • Specialty and Dermatology Clinics
  • Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Teoxane Laboratories
    • Cutera Inc
    • Elan aesthetics Inc
    • Bioxis pharmaceutical
    • AbbVie Laboratories
    • Sinclair Pharma
    • Sosum Global
    • Revance Therapeutics
    • Galderma SA
    • Merz Pharma

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: DERMAL FILLER MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Hyaluronic Acid (HA)
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
    • 4.2.5. Age group
      • 4.2.5.1. Market Size and Forecast
      • 4.2.5.2. 13 to 39
      • 4.2.5.2.1. Market Size and Forecast
      • 4.2.5.2. 40 to 54
      • 4.2.5.2.1. Market Size and Forecast
      • 4.2.5.2. 55 to 69
      • 4.2.5.2.1. Market Size and Forecast
  • 4.3. Calcium Hydroxylapatite (CaHA)
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Poly L Lactic Acid
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Others
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: DERMAL FILLER MARKET, BY GENDER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Gender
  • 5.2. Male
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Female
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Service Provider
  • 6.2. Specialty And Dermatology Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Hospitals
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: DERMAL FILLER MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Gender
    • 7.2.4. Market Size and Forecast, By Service Provider
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Dermal Filler Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Gender
      • 7.2.6.3. Market Size and Forecast, By Service Provider
    • 7.2.7. Canada Dermal Filler Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Gender
      • 7.2.7.3. Market Size and Forecast, By Service Provider
    • 7.2.8. Mexico Dermal Filler Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Gender
      • 7.2.8.3. Market Size and Forecast, By Service Provider
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Gender
    • 7.3.4. Market Size and Forecast, By Service Provider
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Dermal Filler Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Gender
      • 7.3.6.3. Market Size and Forecast, By Service Provider
    • 7.3.7. France Dermal Filler Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Gender
      • 7.3.7.3. Market Size and Forecast, By Service Provider
    • 7.3.8. UK Dermal Filler Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Gender
      • 7.3.8.3. Market Size and Forecast, By Service Provider
    • 7.3.9. Italy Dermal Filler Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Gender
      • 7.3.9.3. Market Size and Forecast, By Service Provider
    • 7.3.10. Spain Dermal Filler Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Gender
      • 7.3.10.3. Market Size and Forecast, By Service Provider
    • 7.3.11. Rest of Europe Dermal Filler Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Gender
      • 7.3.11.3. Market Size and Forecast, By Service Provider
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Gender
    • 7.4.4. Market Size and Forecast, By Service Provider
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Dermal Filler Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Gender
      • 7.4.6.3. Market Size and Forecast, By Service Provider
    • 7.4.7. China Dermal Filler Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Gender
      • 7.4.7.3. Market Size and Forecast, By Service Provider
    • 7.4.8. India Dermal Filler Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Gender
      • 7.4.8.3. Market Size and Forecast, By Service Provider
    • 7.4.9. Australia Dermal Filler Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Gender
      • 7.4.9.3. Market Size and Forecast, By Service Provider
    • 7.4.10. South Korea Dermal Filler Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Gender
      • 7.4.10.3. Market Size and Forecast, By Service Provider
    • 7.4.11. Rest of Asia-Pacific Dermal Filler Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Gender
      • 7.4.11.3. Market Size and Forecast, By Service Provider
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Gender
    • 7.5.4. Market Size and Forecast, By Service Provider
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Dermal Filler Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Gender
      • 7.5.6.3. Market Size and Forecast, By Service Provider
    • 7.5.7. Saudi Arabia Dermal Filler Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Gender
      • 7.5.7.3. Market Size and Forecast, By Service Provider
    • 7.5.8. South Africa Dermal Filler Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Gender
      • 7.5.8.3. Market Size and Forecast, By Service Provider
    • 7.5.9. Rest of LAMEA Dermal Filler Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Gender
      • 7.5.9.3. Market Size and Forecast, By Service Provider

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Teoxane Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Cutera Inc
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Elan Aesthetics Inc
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Bioxis Pharmaceutical
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. AbbVie Laboratories
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Sinclair Pharma
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Sosum Global
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Revance Therapeutics
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Galderma SA
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Merz Pharma
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments